Literature DB >> 15941620

Respiratory and cardiovascular actions of orexin-A in mice.

Wei Zhang1, Yasuichiro Fukuda, Tomoyuki Kuwaki.   

Abstract

Ample evidence has been reported to show a probable contribution of orexin in the central cardiovascular regulation. Although cardiovascular and respiratory centers in the brain are located close to each other and are interconnected, the possible participation of orexin in respiratory regulation has not been fully documented. Here we examined the effects of intracerebroventricular administration of orexin-A on respiratory and cardiovascular parameters in urethane-anesthetized mice. Respiratory frequency and tidal volume were recorded simultaneously with blood pressure and heart rate. Orexin-A (0.003-3 nmol in 2 microL) or vehicle was administered into the lateral ventricle or cisterna magna. Lateral ventricular administration induced a rise in respiratory frequency (by 11% at the highest dose), tidal volume (76%), blood pressure (13%) and heart rate (6%) in a dose-dependent manner. With intracisternal administration, however, respiratory frequency did not change while a similar increase in tidal volume (75%) was observed. A relatively larger cardiovascular response was elicited with intracisternal administration (blood pressure 26%, heart rate 9%). On the other hand, with either administration route, orexin-A did not affect reflex increases in respiratory frequency and tidal volume in response to hypoxia and hypercapnia. These results show possible participation of orexin-A not only in the cardiovascular regulation but also in the respiratory control system. Moreover, orexin can affect the cardiorespiratory control system at multiple sites in different ways. Orexin-A seems not to be involved in respiratory reflex regulation in mice at least under anesthetized condition.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15941620     DOI: 10.1016/j.neulet.2005.05.032

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  27 in total

1.  Functional link between the hypocretin and serotonin systems in the neural control of breathing and central chemosensitivity.

Authors:  Andrea E Corcoran; George B Richerson; Michael B Harris
Journal:  J Neurophysiol       Date:  2015-04-15       Impact factor: 2.714

Review 2.  State-dependent central chemoreception: a role of orexin.

Authors:  Tomoyuki Kuwaki; Aihua Li; Eugene Nattie
Journal:  Respir Physiol Neurobiol       Date:  2010-02-17       Impact factor: 1.931

Review 3.  Implicating the potential role of orexin in hypertension.

Authors:  Monika Rani; Raghuvansh Kumar; Pawan Krishan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-05-16       Impact factor: 3.000

Review 4.  Orexin, stress, and anxiety/panic states.

Authors:  Philip L Johnson; Andrei Molosh; Stephanie D Fitz; William A Truitt; Anantha Shekhar
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

Review 5.  Respiration and autonomic regulation and orexin.

Authors:  Eugene Nattie; Aihua Li
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

6.  Intrathecal orexin A increases sympathetic outflow and respiratory drive, enhances baroreflex sensitivity and blocks the somato-sympathetic reflex.

Authors:  I Z Shahid; A A Rahman; P M Pilowsky
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

Review 7.  Neuropeptides controlling energy balance: orexins and neuromedins.

Authors:  Joshua P Nixon; Catherine M Kotz; Colleen M Novak; Charles J Billington; Jennifer A Teske
Journal:  Handb Exp Pharmacol       Date:  2012

8.  Direct projections from hypothalamic orexin neurons to brainstem cardiac vagal neurons.

Authors:  Olga Dergacheva; Akihiro Yamanaka; Alan R Schwartz; Vsevolod Y Polotsky; David Mendelowitz
Journal:  Neuroscience       Date:  2016-09-28       Impact factor: 3.590

Review 9.  Hypothalamic orexins/hypocretins as regulators of breathing.

Authors:  Rhîannan H Williams; Denis Burdakov
Journal:  Expert Rev Mol Med       Date:  2008-10-02       Impact factor: 5.600

10.  Antagonism of orexin receptor-1 in the retrotrapezoid nucleus inhibits the ventilatory response to hypercapnia predominantly in wakefulness.

Authors:  Mirela Barros Dias; Aihua Li; Eugene E Nattie
Journal:  J Physiol       Date:  2009-03-09       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.